Related Experiment Video
Updated: Aug 5, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Delayed hypersensitivity reaction to allopurinol: A case report
Che Man Mohammad1, Che Alhadi Shahidah2, Suriyani Wan Mahmud Wan Fatimah3
1MD (UKM), MMED (USM), Department of Family Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Indera Mahkota Campus, Kuantan,Pahang, Malaysia.
Allopurinol is a common gout treatment, but can cause rare, severe skin reactions. Doctors should consider this delayed hypersensitivity in patients with gout and rashes on long-term allopurinol therapy.
Area of Science:
- Rheumatology
- Dermatology
- Clinical Pharmacology
Background:
- Allopurinol is a primary treatment for hyperuricemia and gout, valued for its cost-effectiveness in chronic management.
- Common side effects include skin rashes, diarrhea, and nausea.
- A severe, life-threatening complication is Stevens-Johnson syndrome.
Observation:
- This case emphasizes a rare but critical delayed hypersensitivity reaction to allopurinol.
- The patient presented with skin rashes while on long-term allopurinol for gout management.
Findings:
- Delayed hypersensitivity to allopurinol, though uncommon, must be considered in gout patients developing skin rashes.
- Prompt recognition is crucial for accurate diagnosis and appropriate patient management.
Implications:
- Highlights the need for a high index of suspicion for allopurinol hypersensitivity in at-risk patients.
- Ensures correct diagnosis and avoids potentially harmful or unnecessary treatments for patients with gout and skin rashes.
- Underscores the importance of differential diagnosis in managing adverse drug reactions.
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions
Allergic Reactions
Phase II Reactions: Glucuronidation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Desensitization and Tachyphylaxis

